About
Momentum Bioscience specialises in developing rapid diagnostics for bloodstream infections in patients with suspected sepsis. Our flagship technology, SepsiSTAT®, provides actionable, direct-from-blood results within hours, outpacing traditional methods. Founded in 2008, Momentum Bioscience is committed to revolutionising diagnostic timelines for critical clinical specimens in hospital microbiology laboratories. Supported by our founders, business angels, and venture capital, we operate from our headquarters at Milton Park, Oxfordshire, UK. We are currently seeking partners for joint commercialisation to help deliver our game-changing solutions to patients worldwide.
Technologies
Cloudflare DNS
Outlook
Google Cloud Hosting
WordPress.org
Mobile Friendly
Nginx
Google Font API
Gravity Forms
Keywords
sepsis
antimicrobial resistance
in vitro diagnostics
rapid diagnostics
microbiology
bloodstream infections
infectious disease
medical equipment manufacturing
sepsis management
molecular gram detection
blood sample preparation
medical devices
clinical metagenomics
blood culture bypass
blood culture bypass technology
blood sample prep automation
blood culture speed-up
phenotypic ast
services
automated system
automated microbial detection system
bloodstream infection rapid testing
ngs integration
blood sample organism enrichment
antibiotic susceptibility testing
sepsis rapid diagnosis
bacteria detection in blood
phenotypic antibiotic susceptibility testing
blood sample processing
microbial enrichment from blood
Company Information
-
Employees 14
-
Founded 2008
-
Total Funding $357479
Location
Abingdon, England, United Kingdom, OX14 4SA
